$JAZZ
Jazz Pharmaceuticals PLC

2019 Q2 Form 10-Q Financial Statement

#000123252419000044 Filed on August 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q4 2018 Q2
Revenue $534.1M $476.5M $500.5M
YoY Change 6.72% 9.18% 26.9%
Cost Of Revenue $27.70M $26.30M $34.70M
YoY Change -20.17% 4.37% 20.91%
Gross Profit $495.7M $441.0M $461.4M
YoY Change 7.45% 8.93% 27.81%
Gross Profit Margin 92.81% 92.56% 92.19%
Selling, General & Admin $176.0M $161.9M $158.6M
YoY Change 10.99% 13.22% 19.84%
% of Gross Profit 35.5% 36.71% 34.37%
Research & Development $62.38M $56.70M $56.13M
YoY Change 11.14% -23.38% 39.78%
% of Gross Profit 12.58% 12.86% 12.17%
Depreciation & Amortization $65.00M $50.30M $58.80M
YoY Change 10.54% -11.29% 100.68%
% of Gross Profit 13.11% 11.41% 12.74%
Operating Expenses $238.4M $265.1M $347.3M
YoY Change -31.35% -1.81% 51.42%
Operating Profit $204.3M $175.9M $153.2M
YoY Change 33.34% 30.44% -7.18%
Interest Expense -$18.23M -$20.40M -$19.65M
YoY Change -7.19% -10.13% 7.39%
% of Operating Profit -8.93% -11.6% -12.82%
Other Income/Expense, Net
YoY Change
Pretax Income $184.1M $164.6M $129.4M
YoY Change 42.25% 38.79% -8.41%
Income Tax -$78.70M $5.200M $36.50M
% Of Pretax Income -42.74% 3.16% 28.2%
Net Earnings $261.9M $159.5M $92.32M
YoY Change 183.68% -31.32% -12.58%
Net Earnings / Revenue 49.03% 33.47% 18.45%
Basic Earnings Per Share $4.62 $2.69 $1.53
Diluted Earnings Per Share $4.56 $2.64 $1.50
COMMON SHARES
Basic Shares Outstanding 56.71M shares 60.32M shares 60.18M shares
Diluted Shares Outstanding 57.43M shares 61.44M shares

Balance Sheet

Concept 2019 Q2 2018 Q4 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $882.7M $824.6M $815.1M
YoY Change 8.29% 37.2% 155.36%
Cash & Equivalents $637.7M $309.6M $485.1M
Short-Term Investments $621.5M $515.0M $330.0M
Other Short-Term Assets $75.37M $67.57M $55.63M
YoY Change 35.47% -11.88% 52.64%
Inventory $69.00M $52.96M $46.16M
Prepaid Expenses $31.71M $25.02M $33.59M
Receivables $311.2M $263.8M $278.4M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.370B $1.234B $1.307B
YoY Change 4.83% 27.44% 97.27%
LONG-TERM ASSETS
Property, Plant & Equipment $127.2M $200.4M $188.1M
YoY Change -32.38% 17.8% 37.66%
Goodwill $925.0M $927.6M $936.5M
YoY Change -1.23% -2.1% 1.1%
Intangibles $2.688B $2.731B $2.842B
YoY Change -5.43% -8.32% -6.29%
Long-Term Investments
YoY Change
Other Assets $40.84M $42.70M $23.40M
YoY Change 74.48% 160.04% 40.67%
Total Long-Term Assets $4.119B $3.969B $4.042B
YoY Change 1.89% -4.47% -2.4%
TOTAL ASSETS
Total Short-Term Assets $1.370B $1.234B $1.307B
Total Long-Term Assets $4.119B $3.969B $4.042B
Total Assets $5.489B $5.203B $5.349B
YoY Change 2.61% 1.56% 11.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $82.22M $40.60M $31.38M
YoY Change 162.03% 66.62% 9.99%
Accrued Expenses $218.8M $264.9M $258.8M
YoY Change -15.47% 33.26% 52.5%
Deferred Revenue $4.720M $5.414M
YoY Change -37.18%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $33.39M $33.39M $33.39M
YoY Change 0.0% -17.78% -7.5%
Total Short-Term Liabilities $369.5M $345.5M $348.0M
YoY Change 6.19% 17.53% 38.96%
LONG-TERM LIABILITIES
Long-Term Debt $1.568B $1.563B $1.558B
YoY Change 0.61% 1.47% -4.74%
Other Long-Term Liabilities $120.7M $218.9M $205.7M
YoY Change -41.32% 23.93% 42.19%
Total Long-Term Liabilities $1.689B $1.782B $1.764B
YoY Change -4.28% 3.78% -0.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $369.5M $345.5M $348.0M
Total Long-Term Liabilities $1.689B $1.782B $1.764B
Total Liabilities $2.058B $2.127B $2.112B
YoY Change -2.55% 5.79% 3.99%
SHAREHOLDERS EQUITY
Retained Earnings $1.022B $841.1M $1.000B
YoY Change 2.15% -8.38% 44.94%
Common Stock $2.171B $2.114B $2.037B
YoY Change 6.6% 9.2% 18.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.983B $2.757B $2.870B
YoY Change
Total Liabilities & Shareholders Equity $5.489B $5.203B $5.349B
YoY Change 2.61% 1.56% 11.34%

Cashflow Statement

Concept 2019 Q2 2018 Q4 2018 Q2
OPERATING ACTIVITIES
Net Income $261.9M $159.5M $92.32M
YoY Change 183.68% -31.32% -12.58%
Depreciation, Depletion And Amortization $65.00M $50.30M $58.80M
YoY Change 10.54% -11.29% 100.68%
Cash From Operating Activities $148.8M $224.3M $191.9M
YoY Change -22.46% 9.63% 42.04%
INVESTING ACTIVITIES
Capital Expenditures -$41.70M -$5.200M -$115.3M
YoY Change -63.83% -69.23% 1041.58%
Acquisitions
YoY Change
Other Investing Activities $39.00M $38.90M -$75.40M
YoY Change -151.72% -359.33% 277.0%
Cash From Investing Activities -$2.700M $33.70M -$190.6M
YoY Change -98.58% -205.64% 533.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -56.20M -446.4M 28.90M
YoY Change -294.46% 1016.0% -113.47%
NET CHANGE
Cash From Operating Activities 148.8M 224.3M 191.9M
Cash From Investing Activities -2.700M 33.70M -190.6M
Cash From Financing Activities -56.20M -446.4M 28.90M
Net Change In Cash 89.90M -188.4M 30.20M
YoY Change 197.68% -241.97% -127.58%
FREE CASH FLOW
Cash From Operating Activities $148.8M $224.3M $191.9M
Capital Expenditures -$41.70M -$5.200M -$115.3M
Free Cash Flow $190.5M $229.5M $307.2M
YoY Change -37.99% 3.61% 111.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0001232524
dei Entity Registrant Name
EntityRegistrantName
Jazz Pharmaceuticals plc
jazz Discrete Income Tax Expense Benefit
DiscreteIncomeTaxExpenseBenefit
-112000000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
193000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
651000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-440000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-689000 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33500
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L2
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1032470
dei Entity Address Address Line1
EntityAddressAddressLine1
Fifth Floor, Waterloo Exchange,
dei Entity Address Address Line2
EntityAddressAddressLine2
Waterloo Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin 4
dei Entity Address Country
EntityAddressCountry
IE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
D04 E5W7
dei Country Region
CountryRegion
353
dei City Area Code
CityAreaCode
1
dei Local Phone Number
LocalPhoneNumber
634-7800
dei Security12b Title
Security12bTitle
Ordinary shares, nominal value $0.0001 per share
dei Trading Symbol
TradingSymbol
JAZZ
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56621139 shares
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
637739000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309622000 USD
CY2019Q2 us-gaap Investments
Investments
245000000 USD
CY2018Q4 us-gaap Investments
Investments
515000000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
311249000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
263838000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
68999000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
52956000 USD
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
31712000 USD
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25017000 USD
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
75367000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
67572000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
1370066000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1234005000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
127183000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200358000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
144746000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2687941000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2731334000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
924990000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
927630000 USD
CY2019Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
184383000 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
57879000 USD
CY2019Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
8517000 USD
CY2018Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
9589000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40835000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42696000 USD
CY2019Q2 us-gaap Assets
Assets
5488661000 USD
CY2018Q4 us-gaap Assets
Assets
5203491000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
82222000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
40602000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218751000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264887000 USD
CY2019Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
33387000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
33387000 USD
CY2019Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
30413000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
68633000 USD
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1197000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4720000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5414000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
369493000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
345487000 USD
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7221000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9581000 USD
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1567842000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1563025000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
156289000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
283669000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
309097000 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
120713000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
218879000 USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2019Q2 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2018Q4 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2019Q2 jazz Capital Redemption Reserve
CapitalRedemptionReserve
472000 USD
CY2018Q4 jazz Capital Redemption Reserve
CapitalRedemptionReserve
472000 USD
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2171458000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2113630000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-210436000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-197791000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1021879000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
841050000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2983434000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2757422000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5488661000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5203491000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
534133000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500479000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1042319000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
945092000 USD
CY2019Q2 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
27676000 USD
CY2018Q2 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
34714000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
61182000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
343961000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
176014000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
158579000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
365792000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62384000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56132000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
122489000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
118799000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
61576000 USD
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
54959000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
118461000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
107966000 USD
CY2019Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2018Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
42896000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
42896000 USD
CY2019Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
2200000 USD
CY2018Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
58200000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
329850000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
347280000 USD
us-gaap Costs And Expenses
CostsAndExpenses
704293000 USD
us-gaap Costs And Expenses
CostsAndExpenses
704086000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
204283000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
153199000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
338026000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
241006000 USD
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18234000 USD
CY2018Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-19646000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-36156000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-40251000 USD
CY2019Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1933000 USD
CY2018Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2697000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2544000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4425000 USD
CY2019Q2 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
CY2018Q2 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-1425000 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-1425000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
184116000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
129431000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
299326000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
194905000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-78650000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36524000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-49534000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55670000 USD
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-868000 USD
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-586000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1761000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-923000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
261898000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
92321000 USD
us-gaap Net Income Loss
NetIncomeLoss
347099000 USD
us-gaap Net Income Loss
NetIncomeLoss
138312000 USD
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.62
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.30
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.56
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.26
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56707000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60177000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56955000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60053000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57427000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61438000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57753000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61309000 shares
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
261898000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
92321000 USD
us-gaap Net Income Loss
NetIncomeLoss
347099000 USD
us-gaap Net Income Loss
NetIncomeLoss
138312000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13319000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-70814000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7823000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-31961000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3081000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1354000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-4822000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
4558000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10238000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-69460000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12645000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27403000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
272136000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22861000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
334454000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
110909000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2757422000 USD
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
4848000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3057000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13810000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27861000 USD
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
111249000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-22883000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
85201000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
2730447000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7033000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6032000 USD
CY2019Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1003000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28658000 USD
CY2019Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
59869000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10238000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
261898000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2983434000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2713097000 USD
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-298000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10588000 USD
CY2018Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
14594000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24276000 USD
CY2018Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
34546000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
42057000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
45991000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
2786571000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51023000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5447000 USD
CY2018Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1429000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26294000 USD
CY2018Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
21015000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-69460000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
92321000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
2869752000 USD
us-gaap Net Income Loss
NetIncomeLoss
347099000 USD
us-gaap Net Income Loss
NetIncomeLoss
138312000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
118461000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
107966000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
55841000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
50615000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
42896000 USD
us-gaap Depreciation
Depreciation
6894000 USD
us-gaap Depreciation
Depreciation
7457000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
58200000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-7000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-115000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-151347000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-32228000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
2403000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
2670000 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-1425000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
22584000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
21504000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2547000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10996000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
47574000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
54356000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18562000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8938000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15929000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5268000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-694000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1767000 USD
jazz Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-7399000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14096000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7371000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-59031000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
60108000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
29050000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3285000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3054000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3749000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
14177000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
13955000 USD
jazz Increase Decrease In Operating Lease Liabilities Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent
431000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
351100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
359333000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
630000000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
385000000 USD
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
58200000 USD
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
0 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
21911000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
11281000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
25500000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
111102000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
360975000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
505350000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
163414000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-242733000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
16122000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
67058000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14813000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16023000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
16693000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
9023000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
171118000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
55561000 USD
jazz Payments For Proceeds From Tenant Allowance Financing Activities
PaymentsForProceedsFromTenantAllowanceFinancingActivities
0 USD
jazz Payments For Proceeds From Tenant Allowance Financing Activities
PaymentsForProceedsFromTenantAllowanceFinancingActivities
-1253000 USD
us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
0 USD
us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
6406000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-186502000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18702000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1148000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
328117000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
99046000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
309622000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
386035000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
637739000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
485081000 USD
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
105264000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200358000 USD
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104961000 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
149442000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264887000 USD
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
273052000 USD
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
153158000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
309097000 USD
CY2019Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
310586000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
218879000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
841050000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
845898000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Risk</span></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents, investments and derivative contracts. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and investments to the extent recorded on the balance sheet.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We manage our foreign currency transaction risk and interest rate risk within specified guidelines through the use of derivatives. All of our derivative instruments are utilized for risk management purposes, and we do not use derivatives for speculative trading purposes. As of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had foreign exchange forward contracts with notional amounts totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$288.9 million</span></span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, the outstanding foreign exchange forward contracts had a net asset fair value of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.6 million</span></span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had interest rate swap contracts with notional amounts totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$300.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. These outstanding interest rate swap contracts had a net liability fair value of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;">. The counterparties to these contracts are large multinational commercial banks, and we believe the risk of nonperformance is not significant.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the U.S., and to other international distributors and hospitals. Customer creditworthiness is monitored and collateral is not required. We monitor deteriorating economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding. Historically, we have not experienced significant credit losses on our accounts receivable and as of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, allowances on receivables were not material. As of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">two</span><span style="font-family:inherit;font-size:10pt;"> customers accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>88%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, Express Scripts Specialty Distribution Services, Inc. and its affiliates, or Express Scripts, the central pharmacy for Xyrem, which accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>78%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and McKesson Corporation and affiliates, or McKesson, which accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable. As of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">two</span><span style="font-family:inherit;font-size:10pt;"> customers accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>89%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, Express Scripts, which accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>74%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and McKesson, which accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>15%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable. </span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We depend on single source suppliers for most of our products, product candidates and their APIs. With respect to Xyrem, the API is manufactured for us by a single source supplier and the finished product is manufactured both by us in our facility in Athlone, Ireland and by our U.S.-based Xyrem supplier.</span></div>
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
882739000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
882739000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
637739000 USD
CY2019Q2 us-gaap Investments
Investments
245000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
824622000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
824622000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309622000 USD
CY2018Q4 us-gaap Investments
Investments
515000000 USD
CY2019Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
4500000 USD
CY2019Q2 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
1745000 USD
CY2019Q2 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
1587000 USD
CY2018Q4 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
5264000 USD
CY2018Q4 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
1460000 USD
CY2019Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14893000 USD
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10895000 USD
CY2019Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
29185000 USD
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
20743000 USD
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
24921000 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
21318000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
68999000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
52956000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
927630000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2640000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
924990000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3310557000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
763753000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2546804000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3236894000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
647565000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2589329000 USD
CY2019Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3451694000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
763753000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2687941000 USD
CY2018Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3378899000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
647565000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2731334000 USD
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
179843000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
249966000 USD
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
52660000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
49608000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
127183000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200358000 USD
CY2019Q2 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
79134000 USD
CY2018Q4 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
86495000 USD
CY2019Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
49050000 USD
CY2018Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
58543000 USD
CY2019Q2 jazz Accrued Clinical Trial Liability
AccruedClinicalTrialLiability
9780000 USD
CY2018Q4 jazz Accrued Clinical Trial Liability
AccruedClinicalTrialLiability
5904000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8722000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q2 jazz Accrued Interest
AccruedInterest
7531000 USD
CY2018Q4 jazz Accrued Interest
AccruedInterest
7407000 USD
CY2019Q2 jazz Accrued Construction In Progress
AccruedConstructionInProgress
7669000 USD
CY2018Q4 jazz Accrued Construction In Progress
AccruedConstructionInProgress
1065000 USD
CY2019Q2 jazz Accrued Inventory Related Liabilities
AccruedInventoryRelatedLiabilities
7130000 USD
CY2018Q4 jazz Accrued Inventory Related Liabilities
AccruedInventoryRelatedLiabilities
8753000 USD
CY2019Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6275000 USD
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6780000 USD
CY2019Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5101000 USD
CY2018Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2679000 USD
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4083000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2333000 USD
CY2019Q2 jazz Sales Return Reserve
SalesReturnReserve
2395000 USD
CY2018Q4 jazz Sales Return Reserve
SalesReturnReserve
2510000 USD
CY2019Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
270000 USD
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1460000 USD
CY2019Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
0 USD
CY2018Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
58154000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31611000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
22804000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218751000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264887000 USD
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
1601229000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
1596412000 USD
CY2019Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
33387000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
33387000 USD
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1567842000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1563025000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
16693000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
33387000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
608387000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
33387000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
517493000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
575000000 USD
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1784347000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
6056000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
11926000 USD
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
619000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1220000 USD
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
4000 USD
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
158000 USD
us-gaap Sublease Income
SubleaseIncome
320000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
6518000 USD
us-gaap Lease Cost
LeaseCost
12830000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
144746000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8722000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
156289000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
165011000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y1M6D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.053
us-gaap Operating Lease Payments
OperatingLeasePayments
8240000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
152142000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6716000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
21050000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20923000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
20889000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
21066000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
128223000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
218867000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
53856000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
165011000 USD
CY2019Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance On First Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
69600000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-11862000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
783000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12645000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
261898000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
92321000 USD
us-gaap Net Income Loss
NetIncomeLoss
347099000 USD
us-gaap Net Income Loss
NetIncomeLoss
138312000 USD
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56707000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60177000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56955000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60053000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
720000 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1261000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
798000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1256000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57427000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61438000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57753000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61309000 shares
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.62
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.30
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.56
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.26
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
534133000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500479000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1042319000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
945092000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
534133000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500479000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1042319000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
945092000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14995000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3054000 USD
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11941000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28289000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26312000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55841000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50615000 USD
CY2019Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4473000 USD
CY2018Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4846000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
8140000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
8514000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
23816000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
21466000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
47701000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
42101000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-78700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-49500000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55700000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.427
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.165
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.282
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.286
CY2019Q2 jazz Discrete Income Tax Expense Benefit
DiscreteIncomeTaxExpenseBenefit
-112300000 USD

Files In Submission

Name View Source Status
0001232524-19-000044-index-headers.html Edgar Link pending
0001232524-19-000044-index.html Edgar Link pending
0001232524-19-000044.txt Edgar Link pending
0001232524-19-000044-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jazz-20190630.xsd Edgar Link pending
jazz-20190630_cal.xml Edgar Link unprocessable
jazz-20190630_def.xml Edgar Link unprocessable
jazz-20190630_lab.xml Edgar Link unprocessable
jazz-20190630_pre.xml Edgar Link unprocessable
jazz2019q2doc.htm Edgar Link pending
jazz2019q2doc_htm.xml Edgar Link completed
jazzq22019ex104offeriannone.htm Edgar Link pending
jazzq22019ex105lettera.htm Edgar Link pending
jazzq22019ex311.htm Edgar Link pending
jazzq22019ex312.htm Edgar Link pending
jazzq22019ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending